Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Trillenberg

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Muscle & Nerve|March 23, 2022
The difficulty of confirming pharmacovigilance signals in myasthenia gravisPeter Trillenberg
Brain and Cognition|October 7, 2008
Neurophysiology and neuroanatomy of smooth pursuit in humansRebekka Lencer, Peter Trillenberg
The Journal of Antimicrobial Chemotherapy|July 25, 2020
Antibiotic-induced myasthenia worsening-an estimation of risk based on reporting frequencyPeter Trillenberg, Julia Thern
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 18, 2010
How precisely can the regularity of spontaneous activity be recognized acoustically?Peter Trillenberg, Andreas Sprenger
Pharmacoepidemiology and Drug Safety|March 26, 2023
Sensitivity and specificity in signal detection with the reporting odds ratio and the information componentPeter Trillenberg, Andreas Sprenger, Björn Machner
Brain and Behavior|October 30, 2025
Utility of the Predictive Summary Index for Comparison of Diagnostic Protocols in Myasthenia Gravis With Repetitive Nerve Stimulation and Concentric Needle JitterPeter Trillenberg, Daphne Schepers-von Ohlen
Current Opinion in Neurology|April 20, 2004
Eye movements and psychiatric diseasePeter Trillenberg, Rebekka Lencer, Wolfgang Heide
Journal of the Neurological Sciences|October 8, 2015
Cerebellar ataxia with unilateral high frequency vestibulopathy and caloric disinhibitionChristoph Helmchen, Evripides Livitzis, Andreas Sprenger, et al.
European Journal of Neurology|February 10, 2021
Worsening of myasthenia due to antiepileptic, antipsychotic, antidepressant, and sedative medication: An estimation of risk based on reporting frequencyPeter Trillenberg, Alexander Katalinic, Klaus Junghanns, et al.
European Journal of Neurology|June 29, 2021
The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequencyPeter Trillenberg, Alexander Katalinic, Julia Thern, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Muscle & Nerve|March 23, 2022
The difficulty of confirming pharmacovigilance signals in myasthenia gravisPeter Trillenberg
Brain and Cognition|October 7, 2008
Neurophysiology and neuroanatomy of smooth pursuit in humansRebekka Lencer, Peter Trillenberg
The Journal of Antimicrobial Chemotherapy|July 25, 2020
Antibiotic-induced myasthenia worsening-an estimation of risk based on reporting frequencyPeter Trillenberg, Julia Thern
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 18, 2010
How precisely can the regularity of spontaneous activity be recognized acoustically?Peter Trillenberg, Andreas Sprenger
Pharmacoepidemiology and Drug Safety|March 26, 2023
Sensitivity and specificity in signal detection with the reporting odds ratio and the information componentPeter Trillenberg, Andreas Sprenger, Björn Machner
Brain and Behavior|October 30, 2025
Utility of the Predictive Summary Index for Comparison of Diagnostic Protocols in Myasthenia Gravis With Repetitive Nerve Stimulation and Concentric Needle JitterPeter Trillenberg, Daphne Schepers-von Ohlen
Current Opinion in Neurology|April 20, 2004
Eye movements and psychiatric diseasePeter Trillenberg, Rebekka Lencer, Wolfgang Heide
Journal of the Neurological Sciences|October 8, 2015
Cerebellar ataxia with unilateral high frequency vestibulopathy and caloric disinhibitionChristoph Helmchen, Evripides Livitzis, Andreas Sprenger, et al.
European Journal of Neurology|February 10, 2021
Worsening of myasthenia due to antiepileptic, antipsychotic, antidepressant, and sedative medication: An estimation of risk based on reporting frequencyPeter Trillenberg, Alexander Katalinic, Klaus Junghanns, et al.
European Journal of Neurology|June 29, 2021
The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequencyPeter Trillenberg, Alexander Katalinic, Julia Thern, et al.
Pageof 5